KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC
Resource Type
Journal
Authors
Gandhi, Leena ; Rodgriguez-Abreu, Delvys ; Gadgeel, Shirish ; Esteban, Emilio ; Felip, Enriqueta ; De Angelis, Flavia ; Domine, Manuel ; Clingan, Philip ; Hochmair, Maximilian J. ; Powell, Steven ; Cheng, Susanna Yee-Shan ; Bischoff, Helge G. ; Peled, Nir ; Grossi, Francesco ; Jennens, Ross R. ; Reck, Martin ; Hui, Rina ; Garon, Edward B. ; Boyer, Michael ; Rubio-Viqueira, Belen ; Novello, Silvia ; Kurata, Takayasu ; Gray, Jhanelle E. ; Vida, John J. ; Wei, Ziwen ; Yang, Jing ; Raftopoulos, Harry ; Pietanza, M. Catherine ; Garassino, Marina C.
Source
CANCER RESEARCH ; JUL 2018, 78 13, 3p. Supplement: S
Subject
Language
English
ISSN
15387445